Samuel Rubinstein

CIK: 0001742152

Transaction Breakdown

Open Market Buys (P)4 (50.0%)

High conviction signal

Open Market Sales (S)4 (50.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

MDWD

MediWound Ltd.

Director

SSKN

STRATA Skin Sciences, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (8 total)

MDWD
MediWound Ltd.
Sep 1, 2026
Sale(S)
Indirect
525 shares at avg. $12.72$7K
MDWD
MediWound Ltd.
Sep 1, 2026
Purchase(P)
Indirect
525 shares at avg. $12.62$7K
MDWD
MediWound Ltd.
May 29, 2026
Purchase(P)
Direct
150 shares at avg. $14.33$2K
SSKN
STRATA Skin Sciences, Inc.
Nov 18, 2025
Purchase(P)
Direct
2.8K shares at avg. $1.41$4K
SSKN
STRATA Skin Sciences, Inc.
Nov 18, 2025
Purchase(P)
Direct
2.2K shares at avg. $1.40$3K
SSKN
STRATA Skin Sciences, Inc.
Nov 17, 2025
Sale(S)
Direct
1.4K shares at avg. $1.36$2K
SSKN
STRATA Skin Sciences, Inc.
Nov 17, 2025
Sale(S)
Direct
5.5K shares at avg. $1.32$7K
SSKN
STRATA Skin Sciences, Inc.
Nov 17, 2025
Sale(S)
Direct
7.2K shares at avg. $1.34$10K

		Type	Shares	Price		Ownership
Sep 1, 2026	MDWD MediWound Ltd.	Sale(S)	525	$12.72	$6,678	Indirect
Sep 1, 2026	MDWD MediWound Ltd.	Purchase(P)	525	$12.62	$6,626	Indirect
May 29, 2026	MDWD MediWound Ltd.	Purchase(P)	150	$14.33	$2,150	Direct
Nov 18, 2025	SSKN STRATA Skin Sciences, Inc.	Purchase(P)	2,832	$1.41	$3,993	Direct
Nov 18, 2025	SSKN STRATA Skin Sciences, Inc.	Purchase(P)	2,168	$1.40	$3,035	Direct
Nov 17, 2025	SSKN STRATA Skin Sciences, Inc.	Sale(S)	1,394	$1.36	$1,896	Direct
Nov 17, 2025	SSKN STRATA Skin Sciences, Inc.	Sale(S)	5,500	$1.32	$7,260	Direct
Nov 17, 2025	SSKN STRATA Skin Sciences, Inc.	Sale(S)	7,200	$1.34	$9,648	Direct

1-8 of 8 transactions

About Rubinstein Samuel

Rubinstein Samuel (SEC CIK 0001742152) files insider reports with the SEC as Director of MediWound Ltd. (MDWD) and Director of STRATA Skin Sciences, Inc. (SSKN).

Signal8 holds 4 ownership filings by Rubinstein Samuel (1 Form 3, 3 Form 4), filed between Nov 18, 2025 and Sep 2, 2026. Those filings report 8 transactions, from Nov 17, 2025 to Sep 1, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Rubinstein Samuel's filings is in YAVNE.

Recent filings by Rubinstein Samuel

Sep 1, 2026: Open-market sale of MDWD shares (Form 4, code S).
Sep 1, 2026: Open-market purchase of MDWD shares (Form 4, code P).
May 29, 2026: Open-market purchase of MDWD shares (Form 4, code P).
Nov 18, 2025: Open-market purchases of SSKN shares (2 lines, Form 4, code P).
Nov 17, 2025: Open-market sales of SSKN shares (3 lines, Form 4, code S).

Other insiders filing for MediWound Ltd. (MDWD)

Hess Shmuel, COO & Chief Commercial Officer
SHAMIR NACHUM, Director
Fox David Morton, Director
Driver Vickie Rae, Director
Luxenburg Kalfon Hana, Chief Financial Officer
Klinger Ety, Chief Medical Officer

How to read Form 4 transaction codes